# OU Health – FDA Inspection, Apr 29, 2019

Source: https://www.keypedia.com/records/fda_inspections/ou-health/2432bd61-a5d8-4ee2-9557-90eab9ecc2f6
Source feed: FDA_Inspections

> FDA inspection 1091552 of OU Health, April 29, 2019. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1091552
- Company Name: OU Health
- Inspection Date: 2019-04-29
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1252564 - 2024-10-28](https://www.keypedia.com/records/fda_inspections/ou-health/c53d8da6-7234-40c1-972b-bbf48c478bc2)
- FDA Inspection 1021584 - 2017-06-21
- FDA Inspection 909982 - 2014-12-15
- FDA Inspection 808849 - 2012-10-05
- FDA Inspection 725767 - 2011-05-03

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/john-a-iwen/b71cb474-8485-416e-a534-ffaed0319625)

Company: https://www.keypedia.com/companies/ou-health/0a6ed5fb-c04d-4f4a-b871-ec96e6d3cbea

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
